Anandhakrishnan A, Korbonits M
Their therapeutic potential is evident in various disease contexts, including type 2 diabetes, neurodegenerative disorders, and inflammatory bowel disease (IBD)
DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption
Keep an eye on how youre feeling, moving, and lifting, not just what the scales say
Beyond its glucose-lowering effects, Ozempic has been shown to promote weight loss in many patients, which can be particularly beneficial for individuals with type 2 diabetes who are overweight or obese
As we continue to uncover the full scope of GLP-1s impact on the brain, one thing is clearthese medications may be doing far more than just helping with weight loss